AstraZeneca PLC (LON:0A4J)

AstraZeneca Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	177,460	162,287	164,292	173,826	134,436	96,139
Market Cap Growth	-18.07%	-1.22%	-5.49%	29.30%	39.84%	-3.67%
Enterprise Value	196,381	182,260	184,338	197,853	154,735	109,746
Last Close Price	49.71	51.28	50.59	52.49	39.56	32.13
PE Ratio	29.31	28.88	35.14	63.70	1625.31	41.07
PS Ratio	4.30	3.76	4.57	4.72	4.87	4.93
PB Ratio	5.43	4.97	5.34	5.65	4.63	8.39
P/FCF Ratio	21.75	20.45	23.29	24.03	37.36	34.20
P/OCF Ratio	18.16	17.13	20.23	21.35	30.53	27.35
EV/Sales Ratio	4.76	4.22	5.13	5.38	5.60	5.63
EV/EBITDA Ratio	13.84	12.99	16.51	17.35	31.27	21.44
EV/EBIT Ratio	18.78	17.65	24.34	27.05	72.32	34.29
EV/FCF Ratio	24.07	22.96	26.14	27.35	43.01	39.04
Debt / Equity Ratio	0.74	0.75	0.76	0.84	0.85	1.45
Debt / EBITDA Ratio	1.69	1.70	2.04	2.23	4.81	3.15
Debt / FCF Ratio	2.95	3.07	3.30	3.57	6.85	5.92
Asset Turnover	0.52	0.53	0.46	0.44	0.44	0.42
Inventory Turnover	1.65	1.80	1.59	1.26	1.85	1.45
Quick Ratio	0.66	0.67	0.58	0.62	0.67	0.67
Current Ratio	0.86	0.93	0.82	0.86	1.16	0.96
Return on Equity (ROE)	19.67%	17.59%	15.64%	8.63%	0.42%	20.80%
Return on Assets (ROA)	8.28%	7.88%	6.10%	5.46%	2.10%	4.26%
Return on Capital (ROIC)	11.88%	11.53%	8.80%	7.82%	3.26%	7.45%
Return on Capital Employed (ROCE)	18.20%	17.00%	13.70%	12.60%	3.50%	9.40%
Earnings Yield	3.41%	3.46%	2.85%	1.57%	0.06%	2.44%
FCF Yield	4.60%	4.89%	4.29%	4.16%	2.68%	2.92%
Dividend Yield	1.78%	4.83%	4.50%	4.58%	5.36%	6.38%
Payout Ratio	59.51%	65.80%	75.25%	132.72%	3442.86%	111.77%
Buyback Yield / Dilution	-0.06%	-0.06%	-0.13%	-9.32%	-8.68%	-0.92%
Total Shareholder Return	1.71%	4.76%	4.37%	-4.74%	-3.32%	5.46%

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.